How is semax dosed and mixed?

500 mcg of Semax from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

Every vial at a glance. Pick a cell to draw it on the syringe.

Concentration is the vial's amount over its water; units are the dose over the concentration, times 100, on a U-100 syringe.
Vial1 mL of water2 mL of water3 mL of water
10 mg75% set up1110 mg/mL: 250 mcg is 2.5 units, 300 mcg is 3 units, 400 mcg is 4 units, 500 mcg is 5 units5 mg/mL: 250 mcg is 5 units, 300 mcg is 6 units, 400 mcg is 8 units, 500 mcg is 10 units3.333 mg/mL: 250 mcg is 7.5 units, 300 mcg is 9 units, 400 mcg is 12 units, 500 mcg is 15 units
5 mg15% set up115 mg/mL: 250 mcg is 5 units, 300 mcg is 6 units, 400 mcg is 8 units, 500 mcg is 10 units2.5 mg/mL: 250 mcg is 10 units, 300 mcg is 12 units, 400 mcg is 16 units, 500 mcg is 20 units1.667 mg/mL: 250 mcg is 15 units, 300 mcg is 18 units, 400 mcg is 24 units, 500 mcg is 30 units

Most often logged by Milligram users: 500 mcg, 36% logged.11

Jump to a vial 10 mg 5 mg

The Russian label for Semax 0.1% nasal drops gives, in micrograms and days, a single dose of 200 to 2000 (3 to 30 per kg), a whole-day total of 500 to 5000 and a course of 3 to 5, while no label or trial found gives a dose for semax injected from a vial.12

Vial strengths, water and syringe marks

Of the people who logged semax, 75% set up a 10 mg vial and 15% a 5 mg vial.11 A 10 mg vial with 2 mL was set up by 45%, and with 1 mL or 3 mL by 13% each.11

On the water, FDA's briefing cites semax free base as soluble in water up to 2 mg/mL and about 10 mg/mL in phosphate-buffered saline.2 Both logged 10 mg mixes, 2 mL (45%) and 1 mL (13%), come out above that 2 mg/mL.211 For semax acetate, FDA says one withdrawn nominator's certificate of analysis calls it soluble in water, but neither nomination held water solubility data.2

500 mcg of Semax from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

45% set up 10 mg + 2 mL11

500 mcg of Semax from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe. Set to 500 mcg, the dose most often logged by Milligram users (36%).11

Doses and schedules

The Russian label for Semax 0.1% nasal drops puts, in micrograms, 50 in one drop and gives no more than 2 to 3 drops per nostril at a time, with larger doses given in several applications 10 to 15 minutes apart.12 In days and micrograms, it extends the course to 14 if needed, gives a whole-day total of 500 to 5000 (7 to 70 per kg), and its 1% drops hold 500 in one drop.12 In micrograms, the whole-day total is 600 to 900 for optic nerve disease and 200 to 400 for children with minimal brain dysfunction, and for the 1% drops 6000 to 12000 in moderate and 12000 to 20000 in severe stroke.12

FDA counts the human exposure it reviewed as 33-47 healthy adults, 69 adults with medical conditions and 451 children with depression or tics/Tourette syndrome, all by the intranasal route.2

TrialDose and schedulePeopleLength
Kaplan 19962Intranasal 1 mg daily, or 0.25 mg once219 healthy men22 days, or once2
Koroleva 19962Intranasal 0.5 mg/kg once237 adults with pain2Once
Ivanikov 2002231% solution intranasal, 2-4 drops per nostril three times a day, plus basic therapy against basic therapy alone232 adults with refractory peptic ulcer2310 days; ulcer healing on day 14 in 89.5% against 30.8% in controls3
Gusev 19974Daily doses the report calls effective: 12 mg (moderate stroke), 18 mg (severe), with intensive therapy, route not stated430 patients, 80 controls on conventional therapy4Courses of 5 and 10 days4
Gusev 20185Standard regimen 6000 mcg/day, route not stated, semax subgroups against no-semax subgroups5110 patients after stroke, in early and late rehabilitation groups52 courses of 10 days, 20-day interval5
Serdiuk 200761% semax intranasal, 12 mg daily, open-label627 patients, motor neuron disease62 courses of 10 days, 2-week break6
Lebedeva 201872Intranasal 1% semax, 1.2 mg per FDA, against placebo72Healthy volunteers: 14 on semax, 10 on placebo7Scans before and 5 and 20 minutes after dosing7
Dontsova 201580.1% semax intranasal, 600 mg/day as printed, plus conventional therapy860 patients with psoriasis, against 58 on conventional therapy810 days8

Of the people who logged semax, 71% logged doses in mcg and 26% in mg.11 A dose of 500 mcg was set up by 36% of people, the largest share, and doses of 250, 300 and 400 mcg by 10% each.11

Nasal or injected

Of the people who logged semax, 72% logged under the skin, 21% nasal and 7% muscle.11 The Russian label describes intranasal use with a dropper stopper.1 FDA found no study of semax given by subcutaneous injection and could assess safety only for the intranasal route.2 FDA also found no pharmacokinetic study of semax in humans by any route.2 No label or trial found gives a dose or an injection site for an injected route. A 1999 study by Alekseeva and colleagues in 73 patients with posthypoxic encephalopathy describes semax by injection but gives no dose, route or site.9

Storage

The Russian label says to store Semax nasal drops protected from light at not above 10 °C, not frozen.1 The label gives storage only for the finished drops, not for a mixed powder.

FDA's briefing, citing references, reports lyophilized semax free base stable for 4 years at -20°C closed tightly, and the reconstituted solution kept at +4°C for up to 2-7 days.2 Cayman Chemical's research sheet does not recommend storing the aqueous solution for more than one day.10

Frequently asked questions

Is semax approved by FDA?

FDA says neither semax free base nor semax acetate is a component of an FDA-approved drug.2

Is semax dosed by body weight?

The Russian label for Semax 0.1% nasal drops gives a single dose of 3 to 30 per kg of body weight and a whole-day total of 7 to 70 per kg, in micrograms.12

Is semax in a registered trial?

ClinicalTrials.gov searches for semax returned no registered study, and a search of the EU Clinical Trials Register did not return a page.

How the logged figures are counted

Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.

References

  1. RLS (Russian drug encyclopedia), reproducing the registered instruction. Semax nasal drops 0.1% and 1%: instructions for use (RLS drug encyclopedia, based on the manufacturer's official instruction approved 2008; in Russian). 2008. rlsnet.ru
  2. US Food and Drug Administration. FDA briefing document: evaluation of semax-related bulk drug substances for the 503A bulk drug substances list (Pharmacy Compounding Advisory Committee, 23-24 July 2026). 2026. fda.gov
  3. Bulletin of Experimental Biology and Medicine (PubMed record). Therapy of peptic ulcer with semax peptide (Ivanikov and colleagues). 2002. pubmed.ncbi.nlm.nih.gov
  4. Zh Nevrol Psikhiatr Im S S Korsakova (PubMed record). Effectiveness of semax in acute period of hemispheric ischemic stroke (Gusev and colleagues). 1997. pubmed.ncbi.nlm.nih.gov
  5. Zh Nevrol Psikhiatr Im S S Korsakova (PubMed record). The efficacy of semax in the treatment of patients at different stages of ischemic stroke (Gusev and colleagues). 2018. pubmed.ncbi.nlm.nih.gov
  6. Zh Nevrol Psikhiatr Im S S Korsakova (PubMed record). Chronic partial denervation and quality of life in patients with motor neuron disease treated with semax (Serdiuk and colleagues). 2007. pubmed.ncbi.nlm.nih.gov
  7. Bulletin of Experimental Biology and Medicine (PubMed record). Effects of Semax on the Default Mode Network of the Brain (Lebedeva and colleagues). 2018. pubmed.ncbi.nlm.nih.gov
  8. Eksperimentalnaia i Klinicheskaia Farmakologiia (PubMed record). Possible drug correction of lipid metabolism disturbances associated with metabolic syndrome in patients with psoriasis (Dontsova). 2015. pubmed.ncbi.nlm.nih.gov
  9. Anesteziologiia i Reanimatologiia (PubMed record). Use of semax at a follow-up of patients with posthypoxic encephalopathy (Alekseeva and colleagues). 1999. pubmed.ncbi.nlm.nih.gov
  10. Cayman Chemical. Semax, Product Information, Item No. 27719. 2023. cdn.caymanchem.com
  11. Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted